138 related articles for article (PubMed ID: 35665999)
1. Expansion kinetics of graft-versus-host T cell clones in patients with post-liver transplant graft-versus-host disease.
Li M; Song S; Tian G; Zhi Y; Chen Y; Huang H; Jiao W; Yu Y; Lv G
Am J Transplant; 2022 Nov; 22(11):2689-2693. PubMed ID: 35665999
[TBL] [Abstract][Full Text] [Related]
2. Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice.
Wu Y; Fu J; Wang H; Yu XZ
Front Immunol; 2021; 12():778996. PubMed ID: 34950143
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of T-cell receptor repertoire in bone marrow transplant recipients: evidence for oligoclonal T-cell expansion in graft-versus-host disease lesions.
Liu X; Chesnokova V; Forman SJ; Diamond DJ
Blood; 1996 Apr; 87(7):3032-44. PubMed ID: 8639927
[TBL] [Abstract][Full Text] [Related]
4. Lymphohematopoietic graft-versus-host responses promote mixed chimerism in patients receiving intestinal transplantation.
Fu J; Zuber J; Shonts B; Obradovic A; Wang Z; Frangaj K; Meng W; Rosenfeld AM; Waffarn EE; Liou P; Lau SP; Savage TM; Yang S; Rogers K; Danzl NM; Ravella S; Satwani P; Iuga A; Ho SH; Griesemer A; Shen Y; Prak ETL; Martinez M; Kato T; Sykes M
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33630757
[TBL] [Abstract][Full Text] [Related]
5. Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation.
Taylor AL; Gibbs P; Sudhindran S; Key T; Goodman RS; Morgan CH; Watson CJ; Delriviere L; Alexander GJ; Jamieson NV; Bradley JA; Taylor CJ
Transplantation; 2004 Feb; 77(3):441-6. PubMed ID: 14966423
[TBL] [Abstract][Full Text] [Related]
6. Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion.
Orsini E; Alyea EP; Schlossman R; Canning C; Soiffer RJ; Chillemi A; Neuberg D; Anderson KC; Ritz J
Bone Marrow Transplant; 2000 Mar; 25(6):623-32. PubMed ID: 10734296
[TBL] [Abstract][Full Text] [Related]
7. T Cell Repertoire Evolution after Allogeneic Bone Marrow Transplantation: An Organizational Perspective.
Meier JA; Haque M; Fawaz M; Abdeen H; Coffey D; Towlerton A; Abdeen A; Toor A; Warren E; Reed J; Kanakry CG; Keating A; Luznik L; Toor AA
Biol Blood Marrow Transplant; 2019 May; 25(5):868-882. PubMed ID: 30677510
[TBL] [Abstract][Full Text] [Related]
8. Flt3 ligand (FL) treatment of murine donors does not modify graft-versus-host disease (GVHD) but FL treatment of recipients post-bone marrow transplantation accelerates GVHD lethality.
Blazar BR; McKenna HJ; Panoskaltsis-Mortari A; Taylor PA
Biol Blood Marrow Transplant; 2001; 7(4):197-207. PubMed ID: 11349806
[TBL] [Abstract][Full Text] [Related]
9. Changes in the T-cell receptor V beta gene repertoire after allogeneic hematopoietic stem cell transplantation.
Liu QF; Li YQ; Yang D; Zhang Y; Yang LJ; Chen SH; Sun J; Liu XL; Zhou SY
Chin Med J (Engl); 2004 Mar; 117(3):413-8. PubMed ID: 15043783
[TBL] [Abstract][Full Text] [Related]
10. Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation.
Hirokawa M; Matsutani T; Saitoh H; Ichikawa Y; Kawabata Y; Horiuchi T; Kitabayashi A; Yoshioka T; Tsuruta Y; Suzuki R; Miura AB; Sawada K
Bone Marrow Transplant; 2002 Dec; 30(12):915-23. PubMed ID: 12476285
[TBL] [Abstract][Full Text] [Related]
11. Infiltrating T cells during liver graft-versus-host disease show a restricted T-cell repertoire.
Margolis DA; Casper JT; Segura AD; Janczak T; McOlash L; Fisher B; Miller K; Gorski J
Biol Blood Marrow Transplant; 2000; 6(4):408-15. PubMed ID: 10917576
[TBL] [Abstract][Full Text] [Related]
12. Studies on the mechanism of tolerance or graft-versus-host disease in allogeneic bone marrow recipients at the level of cytotoxic T-cell precursor frequencies.
Irschick EU; Hladik F; Niederwieser D; Nussbaumer W; Holler E; Kaminski E; Huber C
Blood; 1992 Mar; 79(6):1622-8. PubMed ID: 1547351
[TBL] [Abstract][Full Text] [Related]
13. Use of anti-CD3 epsilon F(ab')2 fragments in vivo to modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation.
Johnson BD; McCabe C; Hanke CA; Truitt RL
J Immunol; 1995 May; 154(10):5542-54. PubMed ID: 7730653
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the Whole CDR3 T Cell Receptor Repertoire after Hematopoietic Stem Cell Transplantation in 2 Clinical Cohorts.
Shah O; Tamaresis JS; Kenyon LJ; Xu L; Zheng P; Gupta P; Rangarajan K; Lee S; Spellman S; Nikiforow S; Zehnder J; Meyer EH
Biol Blood Marrow Transplant; 2020 Jun; 26(6):1050-1070. PubMed ID: 32081787
[TBL] [Abstract][Full Text] [Related]
15. The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model.
Dey B; Yang YG; Preffer F; Shimizu A; Swenson K; Dombkowski D; Sykes M
Transplantation; 1999 Jul; 68(1):141-9. PubMed ID: 10428282
[TBL] [Abstract][Full Text] [Related]
16. The role of alphabeta- and gammadelta-T cells in allogenic donor marrow on engraftment, chimerism, and graft-versus-host disease.
Huang Y; Cramer DE; Ray MB; Chilton PM; Que X; Ildstad ST
Transplantation; 2001 Dec; 72(12):1907-14. PubMed ID: 11773887
[TBL] [Abstract][Full Text] [Related]
17. Organ-specific T cell receptor repertoire in target organs of murine graft-versus-host after transplantation across minor histocompatibility antigen barriers.
Schilbach K; Schick J; Fluhr H; Marquordt K; Wehrmann M; Schütt BS; Schlegel PG; Niethammer D; Eyrich M
Transplantation; 2004 Jul; 78(1):31-40. PubMed ID: 15257036
[TBL] [Abstract][Full Text] [Related]
18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
19. Intermediate TCR cells with self-reactive clones are effector cells which induce syngeneic graft-versus-host disease in mice.
Osman Y; Watanabe T; Kawachi Y; Sato K; Ohtsuka K; Watanabe H; Hashimoto S; Moriyama Y; Shibata A; Abo T
Cell Immunol; 1995 Dec; 166(2):172-86. PubMed ID: 7497519
[TBL] [Abstract][Full Text] [Related]
20. CD69+ resident memory T cells are associated with graft-versus-host disease in intestinal transplantation.
Weiner J; Svetlicky N; Kang J; Sadat M; Khan K; Duttargi A; Stovroff M; Moturi S; Kara Balla A; Hyang Kwon D; Kallakury B; Hawksworth J; Subramanian S; Yazigi N; Kaufman S; Pasieka HB; Matsumoto CS; Robson SC; Pavletic S; Zasloff M; Fishbein TM; Kroemer A
Am J Transplant; 2021 May; 21(5):1878-1892. PubMed ID: 33226726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
